A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer

The primary objective of this study was to determine the response rates of the gemcitabine and cisplatin combination in unresectable gall bladder cancer patients. The secondary objectives were to evaluate the toxicity, time to progressive disease, and overall survival. Chemonaïve patients with histo...

Descripción completa

Detalles Bibliográficos
Autores principales: Doval, D C, Sekhon, J S, Gupta, S K, Fuloria, J, Shukla, V K, Gupta, S, Awasthy, B S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409709/
https://www.ncbi.nlm.nih.gov/pubmed/15083178
http://dx.doi.org/10.1038/sj.bjc.6601736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409709/
https://www.ncbi.nlm.nih.gov/pubmed/15083178
http://dx.doi.org/10.1038/sj.bjc.6601736

Ejemplares similares